Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study
Anthony J. Maxwell,
Bridget Hilton,
Karen Clements,
David Dodwell,
Joanne Dulson-Cox,
Olive Kearins,
Cliona Kirwan,
Janet Litherland,
Senthurun Mylvaganam,
Elena Provenzano,
Sarah E. Pinder,
Elinor Sawyer,
Abeer M. Shaaban,
Nisha Sharma,
Hilary Stobart,
Matthew G. Wallis,
Alastair M. Thompson
Affiliations
Anthony J. Maxwell
Nightingale Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK; Division of Informatics, Imaging & Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK; Corresponding author. Nightingale Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK.
Bridget Hilton
Public Health England, 5 St Philip's Place, Birmingham, B3 2PW, UK
Karen Clements
Public Health England, 5 St Philip's Place, Birmingham, B3 2PW, UK
David Dodwell
Nuffield Department of Population Health, University of Oxford, Richard Doll Building, Old Road Campus, Oxford, OX3 7LF, UK
Joanne Dulson-Cox
Public Health England, 5 St Philip's Place, Birmingham, B3 2PW, UK
Olive Kearins
Public Health England, 5 St Philip's Place, Birmingham, B3 2PW, UK
Cliona Kirwan
Nightingale Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PT, UK
Janet Litherland
West of Scotland Breast Screening Centre, Nelson Mandela Place, Glasgow, G2 1QY, UK
Senthurun Mylvaganam
New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton Road, Wolverhampton, WV10 0QP, UK
Elena Provenzano
Department of Histopathology (Box 235), Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ, UK
Sarah E. Pinder
Division of Cancer Studies, King's College London, Guy's Hospital, St Thomas Street, London, SE1 9RT, UK
Elinor Sawyer
School of Cancer & Pharmaceutical Sciences, Kings College London, Guy's Cancer Centre, Great Maze Pond, London, SE1 9RT, UK
Abeer M. Shaaban
Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, B15 2GW, UK
Nisha Sharma
Leeds Wakefield Breast Screening Service, Seacroft Hospital, York Road, Leeds, LS14 6UH, UK
Hilary Stobart
Independent Cancer Patients' Voice, 17 Woodbridge Street, London, EC1R 0LL, UK
Matthew G. Wallis
Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge & NIHR Cambridge Biomedical Research Centre, Cambridge, CB2 0QQ, UK
Alastair M. Thompson
Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA
Background and aim: The natural history of ductal carcinoma in situ (DCIS) is poorly understood. The aim of this cohort study was to determine the outcomes of women who had no surgery for screen-detected DCIS in the 6 months following diagnosis. Methods: English breast screening databases were retrospectively searched for women diagnosed with DCIS without invasive cancer at screening and who had no record of surgery within 6 months of diagnosis. These were cross-referenced with cancer registry data. Details of the potentially eligible women were sent to the relevant breast screening units for verification and for completion of data forms detailing clinical, radiological and pathological findings, non-surgical treatment and subsequent clinical course. Results: Data for 311 eligible women (median age 62 years) were available. 60 women developed invasive cancer, 56 ipsilateral and 4 contralateral. Ipsilateral invasion risk increased approximately linearly with time for at least 10 years. The 10-year cumulative risk of ipsilateral invasion was 9% (95% CI 4–21%), 39% (24–58%) and 36% (24–50%) for low, intermediate and high grade DCIS respectively and was higher in younger women, in those with larger DCIS lesions and in those with microinvasion. Most invasive cancers that developed were grade 2 or 3. Conclusion: The findings suggest that active surveillance may be a reasonable alternative to surgery in patients with low grade DCIS but that women with intermediate or high grade disease should continue to be offered surgery. This highlights the importance of reproducible grading of DCIS to ensure patients receive appropriate treatment.